NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|2217338130|ref|XP_047296915|]
View 

reduced folate transporter isoform X7 [Homo sapiens]

Protein Classification

SLC19 family protein( domain architecture ID 11489681)

solute carrier 19 (SLC19) family protein similar to folate and thiamine transporters, which mediate the uptake of folate and thiamine, respectively

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
rfc TIGR00806
RFC reduced folate carrier; The Reduced Folate Carrier (RFC) Family (TC 2.A.48) Members of the ...
18-460 0e+00

RFC reduced folate carrier; The Reduced Folate Carrier (RFC) Family (TC 2.A.48) Members of the RFC family mediate the uptake of folate, reduce folate, derivatives of reduced folate and the drug, methotrexate. Proteins of the RFC family are so-far restricted to animals. RFC proteins possess 12 putative transmembrane a-helical spanners (TMSs) and evidence for a 12 TMS topology has been published for the human RFC. The RFC transporters appear to transport reduced folate by an energy-dependent, pH-dependent, Na+-independent mechanism. Folate:H+ symport, folate:OH- antiport and folate:anion antiport mechanisms have been proposed, but the energetic mechanism is not well defined. [Transport and binding proteins, Carbohydrates, organic alcohols, and acids]


:

Pssm-ID: 129888  Cd Length: 511  Bit Score: 692.39  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  18 VTNEITPVLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARIAYSSYIFSL 97
Cdd:TIGR00806  63 VTNEIIPVLPYSHLAVLVPVFLLTDYLRYKPVLVLQALSFVCVWLLLLLGTSVWHMQLMEVFYSVTMAARIAYSSYIFSL 142
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  98 VRPARYQRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRSLFFNRDDRGRcETS 177
Cdd:TIGR00806 143 VPPSRYQRAAAYSRAAVLLGVFLSSVLGQLLVTLGWISYSTLNIISLVFMTFSVFLALFLKRPKRSLFFNRLEDVR-GAL 221
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 178 ASELERMNPGPGGKLGHALRvACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVDPTTNSar 257
Cdd:TIGR00806 222 PCELDQMVPGPGGKLEDYLG-TCRDSFLVRMLSELVTIYRNPQLLLWSLWWVFNSAGYYLITYYVHTLWGTLDESLNK-- 298
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 258 vYNGAADAASTLLGAITSFAAGFVKIRWARWSKLLIAGVTATQAGLVFLLAHTRHpssIWLCYAAFVLFRGSYQFLVPIA 337
Cdd:TIGR00806 299 -YNGAVDAASTLLGAITSFIAGFVNIRWARWSKLLIAVVSAIQAGLVFWMSQSHD---IWVLYVTYVLFRGIYQFLVPIA 374
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 338 TFQIASSLSKELCALVFGVNTFFATIVKTIITFIVSDVRGLGLPVRKQFQLYSVYFLILSIIYFLGAMLDGLRHCQRGHH 417
Cdd:TIGR00806 375 TFQIASSLSKELCALVFGINTFVATALKTIITAVVSDKRGLGLQVRKQFRIYSVYFLVLSIICFFGAGLDGLRYCKRGTH 454
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|...
gi 2217338130 418 PRQPPAQGLRSaAEEKAAQALSVQDKGLGGLQPaQSPPLSPED 460
Cdd:TIGR00806 455 QPLAPAQELRS-PLEESVQAISLQDRDLRGPQP-SAPQLLPED 495
 
Name Accession Description Interval E-value
rfc TIGR00806
RFC reduced folate carrier; The Reduced Folate Carrier (RFC) Family (TC 2.A.48) Members of the ...
18-460 0e+00

RFC reduced folate carrier; The Reduced Folate Carrier (RFC) Family (TC 2.A.48) Members of the RFC family mediate the uptake of folate, reduce folate, derivatives of reduced folate and the drug, methotrexate. Proteins of the RFC family are so-far restricted to animals. RFC proteins possess 12 putative transmembrane a-helical spanners (TMSs) and evidence for a 12 TMS topology has been published for the human RFC. The RFC transporters appear to transport reduced folate by an energy-dependent, pH-dependent, Na+-independent mechanism. Folate:H+ symport, folate:OH- antiport and folate:anion antiport mechanisms have been proposed, but the energetic mechanism is not well defined. [Transport and binding proteins, Carbohydrates, organic alcohols, and acids]


Pssm-ID: 129888  Cd Length: 511  Bit Score: 692.39  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  18 VTNEITPVLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARIAYSSYIFSL 97
Cdd:TIGR00806  63 VTNEIIPVLPYSHLAVLVPVFLLTDYLRYKPVLVLQALSFVCVWLLLLLGTSVWHMQLMEVFYSVTMAARIAYSSYIFSL 142
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  98 VRPARYQRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRSLFFNRDDRGRcETS 177
Cdd:TIGR00806 143 VPPSRYQRAAAYSRAAVLLGVFLSSVLGQLLVTLGWISYSTLNIISLVFMTFSVFLALFLKRPKRSLFFNRLEDVR-GAL 221
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 178 ASELERMNPGPGGKLGHALRvACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVDPTTNSar 257
Cdd:TIGR00806 222 PCELDQMVPGPGGKLEDYLG-TCRDSFLVRMLSELVTIYRNPQLLLWSLWWVFNSAGYYLITYYVHTLWGTLDESLNK-- 298
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 258 vYNGAADAASTLLGAITSFAAGFVKIRWARWSKLLIAGVTATQAGLVFLLAHTRHpssIWLCYAAFVLFRGSYQFLVPIA 337
Cdd:TIGR00806 299 -YNGAVDAASTLLGAITSFIAGFVNIRWARWSKLLIAVVSAIQAGLVFWMSQSHD---IWVLYVTYVLFRGIYQFLVPIA 374
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 338 TFQIASSLSKELCALVFGVNTFFATIVKTIITFIVSDVRGLGLPVRKQFQLYSVYFLILSIIYFLGAMLDGLRHCQRGHH 417
Cdd:TIGR00806 375 TFQIASSLSKELCALVFGINTFVATALKTIITAVVSDKRGLGLQVRKQFRIYSVYFLVLSIICFFGAGLDGLRYCKRGTH 454
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|...
gi 2217338130 418 PRQPPAQGLRSaAEEKAAQALSVQDKGLGGLQPaQSPPLSPED 460
Cdd:TIGR00806 455 QPLAPAQELRS-PLEESVQAISLQDRDLRGPQP-SAPQLLPED 495
Folate_carrier pfam01770
Reduced folate carrier; The reduced folate carrier (a transmembrane glycoprotein) transports ...
18-388 0e+00

Reduced folate carrier; The reduced folate carrier (a transmembrane glycoprotein) transports reduced folate into mammalian cells via the carrier mediated mechanism (as opposed to the receptor mediated mechanism) it also transports cytotoxic folate analogues used in chemotherapy, such as methotrexate (MTX). Mammalian cells have an absolute requirement for exogenous folates which are needed for growth, and biosynthesis of macromolecules.


Pssm-ID: 460318  Cd Length: 412  Bit Score: 538.41  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  18 VTNEITPVLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARIAYSSYIFSL 97
Cdd:pfam01770  42 VTNEVYPVWTYSYLALLVPVFLLTDYLRYKPVIVLQGLSYVTCWLLLIFGTSVLAMQFMEFFYGVATAAEVAYYSYIYSL 121
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  98 VRPARYQRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRSLFFNRdDRGRCETS 177
Cdd:pfam01770 122 VDPERYQRVTSYSRAAVLVGYFVSSVLGQLLVSLAGMSYFTLNYISLASVVVALFLSLFLPRPKRSLFFHK-KELASEKD 200
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 178 ASELERMNPGPGGKLG-----HALRVACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVdPT 252
Cdd:pfam01770 201 TVSDETLHNGPEQENGkendlEASSIGTRKMVLVLMWRELKECYSNPLLLQWSLWWAFATAGYYQVVNYVQVLWEDV-PP 279
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 253 TNSARVYNGAADAASTLLGAITSFAAGFVKIRWARWSKLLIAGVTATQAGLVFLLAHTRhpsSIWLCYAAFVLFRGSYQF 332
Cdd:pfam01770 280 SDNASVYNGAVEAASTLLGAIAALAAGYLKVNWKRWGELVLGVLSALQAGLLFLMFVTH---SIWLCYAGYVLFRASYQF 356
                         330       340       350       360       370
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2217338130 333 LVPIATFQIASSLSKELCALVFGVNTFFATIVKTIITFIVSDVRGLGLPVRKQFQL 388
Cdd:pfam01770 357 LITIATFQIAANLSLERYALVFGINTFVALALQTILTAIVVDKRGLGLDVRPQFLV 412
MFS cd06174
Major Facilitator Superfamily; The Major Facilitator Superfamily (MFS) is a large and diverse ...
25-406 5.41e-06

Major Facilitator Superfamily; The Major Facilitator Superfamily (MFS) is a large and diverse group of secondary transporters that includes uniporters, symporters, and antiporters. MFS proteins facilitate the transport across cytoplasmic or internal membranes of a variety of substrates including ions, sugar phosphates, drugs, neurotransmitters, nucleosides, amino acids, and peptides. They do so using the electrochemical potential of the transported substrates. Uniporters transport a single substrate, while symporters and antiporters transport two substrates in the same or in opposite directions, respectively, across membranes. MFS proteins are typically 400 to 600 amino acids in length, and the majority contain 12 transmembrane alpha helices (TMs) connected by hydrophilic loops. The N- and C-terminal halves of these proteins display weak similarity and may be the result of a gene duplication/fusion event. Based on kinetic studies and the structures of a few bacterial superfamily members, GlpT (glycerol-3-phosphate transporter), LacY (lactose permease), and EmrD (multidrug transporter), MFS proteins are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement. Bacterial members function primarily for nutrient uptake, and as drug-efflux pumps to confer antibiotic resistance. Some MFS proteins have medical significance in humans such as the glucose transporter Glut4, which is impaired in type II diabetes, and glucose-6-phosphate transporter (G6PT), which causes glycogen storage disease when mutated.


Pssm-ID: 349949 [Multi-domain]  Cd Length: 378  Bit Score: 48.58  E-value: 5.41e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  25 VLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSV-TMAARIAYSSYIFSLVRPARY 103
Cdd:cd06174    39 LFSLGYALLQPLAGLLADRFGRRPVLLLGLLLFALGALLFAFAPSFWLLLLGRFLLGLgSGLIDPAVLALIADLFPERER 118
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 104 QRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRslffnrddrgrcetsaseler 183
Cdd:cd06174   119 GRALGLLQAFGSVGGILGPLLGGILASSLGFGWRAVFLIAAALALLAAILLLLVVPDPP--------------------- 177
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 184 mnpgpggklgHALRVACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVDPTTNSARVYNGAA 263
Cdd:cd06174   178 ----------ESARAKNEEASSKSVLKLLKRVLKNPGLWLLLLAIFLVNLAYYSFSTLLPLFLLDLGGLSVAVAGLLLSL 247
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 264 daaSTLLGAITSFAAGFVKIRWARWSKLLIAGVtATQAGLVFLLAHTRHPSSIWLCYAAFVLFRGSYQflvPIATFQIAS 343
Cdd:cd06174   248 ---FGLAGALGSLLLGLLSDRLIGRKPLLLIGL-LLMALGLALLLLAPSLLLLLLLLLLLGFGLGGLL---PLSFALIAE 320
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 2217338130 344 SLSKELCALVFGVNTFFATIVKTIITFIVSdvrglglPVRKQFQLYSVYFLILSIIYFLGAML 406
Cdd:cd06174   321 LFPPEIRGTAFGLLNTFGFLGGAIGPLLAG-------FLLAATFGLTGAFLVLAVLLLLAAIL 376
AraJ COG2814
Predicted arabinose efflux permease AraJ, MFS family [Carbohydrate transport and metabolism];
32-363 2.87e-04

Predicted arabinose efflux permease AraJ, MFS family [Carbohydrate transport and metabolism];


Pssm-ID: 442063 [Multi-domain]  Cd Length: 348  Bit Score: 43.04  E-value: 2.87e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  32 AVLVPVF-LLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARI-AYSSYIFSLVRPARYQRVAGY 109
Cdd:COG2814    59 ALGAPLAgRLADRFGRRRVLLLGLLLFALGSLLCALAPSLWLLLAARFLQGLGAGALFpAALALIADLVPPERRGRALGL 138
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 110 SRAAVLLGVFTSSVLGQLLVTVgrVSFSTLNYISLAFLTFSVVLALFLkrpkrslffnrddrgrcetsaseLERMNPGPG 189
Cdd:COG2814   139 LGAGLGLGPALGPLLGGLLADL--FGWRWVFLVNAVLALLALLLLLRL-----------------------LPESRPAAR 193
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 190 GKLGHALRvacgdsvlarmlrelgDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVdptTNSARVYNGAADAASTL 269
Cdd:COG2814   194 ARLRGSLR----------------ELLRRPRLLLLLLLAFLLGFGFFALFTYLPLYLQEV---LGLSASAAGLLLALFGL 254
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 270 LGAITSFAAGFVKIRWARWsKLLIAGVTATQAGLVFLLAhtrhPSSIWLCYAAFVLFRGSYQFLVPIATFQIASSLSKEL 349
Cdd:COG2814   255 GGVLGALLAGRLADRFGRR-RLLLIGLLLLALGLLLLAL----AGSLWLLLLALFLLGFGFGLLFPLLQALVAELAPPEA 329
                         330
                  ....*....|....
gi 2217338130 350 CALVFGVNTFFATI 363
Cdd:COG2814   330 RGRASGLYNSAFFL 343
 
Name Accession Description Interval E-value
rfc TIGR00806
RFC reduced folate carrier; The Reduced Folate Carrier (RFC) Family (TC 2.A.48) Members of the ...
18-460 0e+00

RFC reduced folate carrier; The Reduced Folate Carrier (RFC) Family (TC 2.A.48) Members of the RFC family mediate the uptake of folate, reduce folate, derivatives of reduced folate and the drug, methotrexate. Proteins of the RFC family are so-far restricted to animals. RFC proteins possess 12 putative transmembrane a-helical spanners (TMSs) and evidence for a 12 TMS topology has been published for the human RFC. The RFC transporters appear to transport reduced folate by an energy-dependent, pH-dependent, Na+-independent mechanism. Folate:H+ symport, folate:OH- antiport and folate:anion antiport mechanisms have been proposed, but the energetic mechanism is not well defined. [Transport and binding proteins, Carbohydrates, organic alcohols, and acids]


Pssm-ID: 129888  Cd Length: 511  Bit Score: 692.39  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  18 VTNEITPVLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARIAYSSYIFSL 97
Cdd:TIGR00806  63 VTNEIIPVLPYSHLAVLVPVFLLTDYLRYKPVLVLQALSFVCVWLLLLLGTSVWHMQLMEVFYSVTMAARIAYSSYIFSL 142
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  98 VRPARYQRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRSLFFNRDDRGRcETS 177
Cdd:TIGR00806 143 VPPSRYQRAAAYSRAAVLLGVFLSSVLGQLLVTLGWISYSTLNIISLVFMTFSVFLALFLKRPKRSLFFNRLEDVR-GAL 221
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 178 ASELERMNPGPGGKLGHALRvACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVDPTTNSar 257
Cdd:TIGR00806 222 PCELDQMVPGPGGKLEDYLG-TCRDSFLVRMLSELVTIYRNPQLLLWSLWWVFNSAGYYLITYYVHTLWGTLDESLNK-- 298
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 258 vYNGAADAASTLLGAITSFAAGFVKIRWARWSKLLIAGVTATQAGLVFLLAHTRHpssIWLCYAAFVLFRGSYQFLVPIA 337
Cdd:TIGR00806 299 -YNGAVDAASTLLGAITSFIAGFVNIRWARWSKLLIAVVSAIQAGLVFWMSQSHD---IWVLYVTYVLFRGIYQFLVPIA 374
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 338 TFQIASSLSKELCALVFGVNTFFATIVKTIITFIVSDVRGLGLPVRKQFQLYSVYFLILSIIYFLGAMLDGLRHCQRGHH 417
Cdd:TIGR00806 375 TFQIASSLSKELCALVFGINTFVATALKTIITAVVSDKRGLGLQVRKQFRIYSVYFLVLSIICFFGAGLDGLRYCKRGTH 454
                         410       420       430       440
                  ....*....|....*....|....*....|....*....|...
gi 2217338130 418 PRQPPAQGLRSaAEEKAAQALSVQDKGLGGLQPaQSPPLSPED 460
Cdd:TIGR00806 455 QPLAPAQELRS-PLEESVQAISLQDRDLRGPQP-SAPQLLPED 495
Folate_carrier pfam01770
Reduced folate carrier; The reduced folate carrier (a transmembrane glycoprotein) transports ...
18-388 0e+00

Reduced folate carrier; The reduced folate carrier (a transmembrane glycoprotein) transports reduced folate into mammalian cells via the carrier mediated mechanism (as opposed to the receptor mediated mechanism) it also transports cytotoxic folate analogues used in chemotherapy, such as methotrexate (MTX). Mammalian cells have an absolute requirement for exogenous folates which are needed for growth, and biosynthesis of macromolecules.


Pssm-ID: 460318  Cd Length: 412  Bit Score: 538.41  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  18 VTNEITPVLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARIAYSSYIFSL 97
Cdd:pfam01770  42 VTNEVYPVWTYSYLALLVPVFLLTDYLRYKPVIVLQGLSYVTCWLLLIFGTSVLAMQFMEFFYGVATAAEVAYYSYIYSL 121
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  98 VRPARYQRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRSLFFNRdDRGRCETS 177
Cdd:pfam01770 122 VDPERYQRVTSYSRAAVLVGYFVSSVLGQLLVSLAGMSYFTLNYISLASVVVALFLSLFLPRPKRSLFFHK-KELASEKD 200
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 178 ASELERMNPGPGGKLG-----HALRVACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVdPT 252
Cdd:pfam01770 201 TVSDETLHNGPEQENGkendlEASSIGTRKMVLVLMWRELKECYSNPLLLQWSLWWAFATAGYYQVVNYVQVLWEDV-PP 279
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 253 TNSARVYNGAADAASTLLGAITSFAAGFVKIRWARWSKLLIAGVTATQAGLVFLLAHTRhpsSIWLCYAAFVLFRGSYQF 332
Cdd:pfam01770 280 SDNASVYNGAVEAASTLLGAIAALAAGYLKVNWKRWGELVLGVLSALQAGLLFLMFVTH---SIWLCYAGYVLFRASYQF 356
                         330       340       350       360       370
                  ....*....|....*....|....*....|....*....|....*....|....*.
gi 2217338130 333 LVPIATFQIASSLSKELCALVFGVNTFFATIVKTIITFIVSDVRGLGLPVRKQFQL 388
Cdd:pfam01770 357 LITIATFQIAANLSLERYALVFGINTFVALALQTILTAIVVDKRGLGLDVRPQFLV 412
MFS_1 pfam07690
Major Facilitator Superfamily;
30-363 3.35e-06

Major Facilitator Superfamily;


Pssm-ID: 429598 [Multi-domain]  Cd Length: 344  Bit Score: 49.34  E-value: 3.35e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  30 YLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARIAYSSYIFS-LVRPARYQRVAG 108
Cdd:pfam07690  45 YALAQPLAGRLSDRFGRRRVLLIGLLLFALGLLLLLFASSLWLLLVLRVLQGLGAGALFPAALALIAdWFPPEERGRALG 124
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 109 YSRAAVLLGVFTSSVLGQLLVTVGrvSFSTLNYISLAFLTFSVVLALFLKRPKRslffnrddrgrcetsaSELERMNPGP 188
Cdd:pfam07690 125 LVSAGFGLGAALGPLLGGLLASLF--GWRAAFLILAILSLLAAVLLLLPRPPPE----------------SKRPKPAEEA 186
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 189 GGKLGHALRVACGDSVLARMlrelgdslrrpqLRLWSLWWVFNSAGYYLVVYYVHILWNEvdpttnsarVYNGAADAAST 268
Cdd:pfam07690 187 RLSLIVAWKALLRDPVLWLL------------LALLLFGFAFFGLLTYLPLYQEVLGLSA---------LLAGLLLGLGG 245
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 269 LLGAITSFAAGFVKIRWARWSKLLIAGVTAtqAGLVFLLAHTRHPSSIWLCYAAFVLFRGSYQFLVPIATFQIASSLSKE 348
Cdd:pfam07690 246 LLGAIGRLLLGRLSDRLGRRRRLLLALLLL--ILAALGLLLLSLTLSSLWLLLALLLLGFGFGLVFPALNALVSDLAPKE 323
                         330
                  ....*....|....*
gi 2217338130 349 LCALVFGVNTFFATI 363
Cdd:pfam07690 324 ERGTASGLYNTAGSL 338
MFS cd06174
Major Facilitator Superfamily; The Major Facilitator Superfamily (MFS) is a large and diverse ...
25-406 5.41e-06

Major Facilitator Superfamily; The Major Facilitator Superfamily (MFS) is a large and diverse group of secondary transporters that includes uniporters, symporters, and antiporters. MFS proteins facilitate the transport across cytoplasmic or internal membranes of a variety of substrates including ions, sugar phosphates, drugs, neurotransmitters, nucleosides, amino acids, and peptides. They do so using the electrochemical potential of the transported substrates. Uniporters transport a single substrate, while symporters and antiporters transport two substrates in the same or in opposite directions, respectively, across membranes. MFS proteins are typically 400 to 600 amino acids in length, and the majority contain 12 transmembrane alpha helices (TMs) connected by hydrophilic loops. The N- and C-terminal halves of these proteins display weak similarity and may be the result of a gene duplication/fusion event. Based on kinetic studies and the structures of a few bacterial superfamily members, GlpT (glycerol-3-phosphate transporter), LacY (lactose permease), and EmrD (multidrug transporter), MFS proteins are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement. Bacterial members function primarily for nutrient uptake, and as drug-efflux pumps to confer antibiotic resistance. Some MFS proteins have medical significance in humans such as the glucose transporter Glut4, which is impaired in type II diabetes, and glucose-6-phosphate transporter (G6PT), which causes glycogen storage disease when mutated.


Pssm-ID: 349949 [Multi-domain]  Cd Length: 378  Bit Score: 48.58  E-value: 5.41e-06
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  25 VLSYSYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSV-TMAARIAYSSYIFSLVRPARY 103
Cdd:cd06174    39 LFSLGYALLQPLAGLLADRFGRRPVLLLGLLLFALGALLFAFAPSFWLLLLGRFLLGLgSGLIDPAVLALIADLFPERER 118
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 104 QRVAGYSRAAVLLGVFTSSVLGQLLVTVGRVSFSTLNYISLAFLTFSVVLALFLKRPKRslffnrddrgrcetsaseler 183
Cdd:cd06174   119 GRALGLLQAFGSVGGILGPLLGGILASSLGFGWRAVFLIAAALALLAAILLLLVVPDPP--------------------- 177
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 184 mnpgpggklgHALRVACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVDPTTNSARVYNGAA 263
Cdd:cd06174   178 ----------ESARAKNEEASSKSVLKLLKRVLKNPGLWLLLLAIFLVNLAYYSFSTLLPLFLLDLGGLSVAVAGLLLSL 247
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 264 daaSTLLGAITSFAAGFVKIRWARWSKLLIAGVtATQAGLVFLLAHTRHPSSIWLCYAAFVLFRGSYQflvPIATFQIAS 343
Cdd:cd06174   248 ---FGLAGALGSLLLGLLSDRLIGRKPLLLIGL-LLMALGLALLLLAPSLLLLLLLLLLLGFGLGGLL---PLSFALIAE 320
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|...
gi 2217338130 344 SLSKELCALVFGVNTFFATIVKTIITFIVSdvrglglPVRKQFQLYSVYFLILSIIYFLGAML 406
Cdd:cd06174   321 LFPPEIRGTAFGLLNTFGFLGGAIGPLLAG-------FLLAATFGLTGAFLVLAVLLLLAAIL 376
AraJ COG2814
Predicted arabinose efflux permease AraJ, MFS family [Carbohydrate transport and metabolism];
32-363 2.87e-04

Predicted arabinose efflux permease AraJ, MFS family [Carbohydrate transport and metabolism];


Pssm-ID: 442063 [Multi-domain]  Cd Length: 348  Bit Score: 43.04  E-value: 2.87e-04
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  32 AVLVPVF-LLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARI-AYSSYIFSLVRPARYQRVAGY 109
Cdd:COG2814    59 ALGAPLAgRLADRFGRRRVLLLGLLLFALGSLLCALAPSLWLLLAARFLQGLGAGALFpAALALIADLVPPERRGRALGL 138
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 110 SRAAVLLGVFTSSVLGQLLVTVgrVSFSTLNYISLAFLTFSVVLALFLkrpkrslffnrddrgrcetsaseLERMNPGPG 189
Cdd:COG2814   139 LGAGLGLGPALGPLLGGLLADL--FGWRWVFLVNAVLALLALLLLLRL-----------------------LPESRPAAR 193
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 190 GKLGHALRvacgdsvlarmlrelgDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVdptTNSARVYNGAADAASTL 269
Cdd:COG2814   194 ARLRGSLR----------------ELLRRPRLLLLLLLAFLLGFGFFALFTYLPLYLQEV---LGLSASAAGLLLALFGL 254
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 270 LGAITSFAAGFVKIRWARWsKLLIAGVTATQAGLVFLLAhtrhPSSIWLCYAAFVLFRGSYQFLVPIATFQIASSLSKEL 349
Cdd:COG2814   255 GGVLGALLAGRLADRFGRR-RLLLIGLLLLALGLLLLAL----AGSLWLLLLALFLLGFGFGLLFPLLQALVAELAPPEA 329
                         330
                  ....*....|....
gi 2217338130 350 CALVFGVNTFFATI 363
Cdd:COG2814   330 RGRASGLYNSAFFL 343
MFS_MdtG_SLC18_like cd17325
bacterial MdtG-like and eukaryotic solute carrier 18 (SLC18) family of the Major Facilitator ...
29-404 2.47e-03

bacterial MdtG-like and eukaryotic solute carrier 18 (SLC18) family of the Major Facilitator Superfamily of transporters; This family is composed of eukaryotic solute carrier 18 (SLC18) family transporters and related bacterial multidrug resistance (MDR) transporters including several proteins from Escherichia coli such as multidrug resistance protein MdtG, from Bacillus subtilis such as multidrug resistance proteins 1 (Bmr1) and 2 (Bmr2), and from Staphylococcus aureus such as quinolone resistance protein NorA. The family also includes Escherichia coli arabinose efflux transporters YfcJ and YhhS. MDR transporters are drug/H+ antiporters (DHA) that mediate the efflux of a variety of drugs and toxic compounds, and confer resistance to these compounds. The SLC18 transporter family includes vesicular monoamine transporters (VAT1 and VAT2), vesicular acetylcholine transporter (VAChT), and SLC18B1, which is proposed to be a vesicular polyamine transporter (VPAT). The MdtG/SLC18 family belongs to the Major Facilitator Superfamily (MFS) of membrane transport proteins, which are thought to function through a single substrate binding site, alternating-access mechanism involving a rocker-switch type of movement.


Pssm-ID: 340883 [Multi-domain]  Cd Length: 375  Bit Score: 40.25  E-value: 2.47e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  29 SYLAVLVPVFLLTDYLRYTPVLLLQGLSFVSVWLLLLLGHSVAHMQLMELFYSVTMAARI-AYSSYIFSLVRPARYQRVA 107
Cdd:cd17325    43 AQLLFSPPAGRLSDRFGRKRLLLLGLLLLAVSTLLFAFATSYWQLLLARFLQGLASAAVWpAAMALIADIAPPEERGRAM 122
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 108 GYSRAAVLLGVFTSSVLGQLLVTVGrvSFSTLNYISLAFLTFSVVLALFLKRPKRSlffnrddrgrcetsaselermnpg 187
Cdd:cd17325   123 GIFSSAIGLGFLIGPLLGGLLADAL--GYRAPFLVCAALALLALVLALLLLPEPRP------------------------ 176
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 188 pggklghalRVACGDSVLARMLRELGDSLRRPQLRLWSLWWVFNSAGYYLVVYYVHILWNEVDPTTNSArvyNGAADAAS 267
Cdd:cd17325   177 ---------PPNKRAVSAARLRSGLRLLLRDRRLLALFLAIFVLAFAFGALEPFLPLYAAELGGLSPAQ---IGLLFGAQ 244
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 268 TLLGAITSFAAGFVKIRWARWsKLLIAGVTATQAGLVFLLahtrHPSSIWLCYAAFVLFRGSYQFLVPIATFQIASSLSK 347
Cdd:cd17325   245 GLASALSQPPAGKLSDRIGRK-PLILIGLLLSAVALLLLP----LATSFWLLLLLLALLGLGLGLVFPATLALLADIVPP 319
                         330       340       350       360       370       380
                  ....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 348 ELCALVFGVNTFFATIVKTIITFI---VSDVRGLGLPvrkqFQLYSVYFLILSIIYFLGA 404
Cdd:cd17325   320 EGRGTAMGLFNTAFSLGMVLGPLLggfLYDAFGFATP----FLAAAALLLLAAVLFLLLR 375
MelB COG2211
Na+/melibiose symporter or related transporter [Carbohydrate transport and metabolism];
45-406 7.28e-03

Na+/melibiose symporter or related transporter [Carbohydrate transport and metabolism];


Pssm-ID: 441813 [Multi-domain]  Cd Length: 447  Bit Score: 39.12  E-value: 7.28e-03
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130  45 RYTPVLL----LQGLSFVSVWLLLLLGHS-------VAHMqLMELFYSVTMaarIAYSSYIFSLVRPARYQ-RVAGYSRA 112
Cdd:COG2211    79 RRRPWILigaiPLALSFVLLFTAPDLSPTgkliyalVTYL-LLGLAYTLVN---IPYSALGAELTPDYEERtRLSSWRFA 154
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 113 AVLLGVFTSSVLGQLLVTVgrVSFSTLNYISLAFLTFSVVLALFLkrpkRSLFFNRDDRGRCETSASELermnpgpggkl 192
Cdd:COG2211   155 FAGLGGLLASVLPPPLVAA--FGGDAALGYRLTALIFAVLGLLAF----LLTFFGTKERPVPEEEKVSL----------- 217
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 193 ghalrvacgdsvlarmLRELGDSLRRPQLRLWSLWWVFNSAGYYLV----VYYVhilwnevdpttnsaRVYNGAADAAST 268
Cdd:COG2211   218 ----------------KESLKALLKNRPFLLLLLAYLLFFLALALVaallLYYF--------------KYVLGLSAALVG 267
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 2217338130 269 LLGAITSFAAGFVKIRWARWSK-------LLIAGVTATQAGLVFLLAHTRHPSSIWLCYAAFVLFRGSYQFLVP------ 335
Cdd:COG2211   268 LLLALYFLAALLGAPLWPRLAKrfgkkkaFIIGLLLAALGLLLLFFLGPGNLWLLLVLAALAGIGLGAILVLPWamladv 347
                         330       340       350       360       370       380       390
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*...
gi 2217338130 336 IATFQIASSLSKElcALVFGVNTFF---ATIVKTIITFIVSD----VRGLGLPVRKQFQLYSVYFLILSIIYFLGAML 406
Cdd:COG2211   348 VDYDEWKTGRRRE--GLYFGIFTFAiklGQALAGALAGLLLAlfgyVAGAAQSPSALTGIRLLFFLLPAVLLLLAALL 423
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH